Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study.
Loche S, Kanumakala S, Backeljauw P, Schwab KO, Lechuga-Sancho AM, Esmael A, Urosevic D, Boldea A, Zabransky M. Loche S, et al. Among authors: urosevic d. Drug Des Devel Ther. 2024 Mar 2;18:667-684. doi: 10.2147/DDDT.S440009. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38454934 Free PMC article.
Microbiology of Healthcare-Associated Infections: Results of a Fourth National Point Prevalence Survey in Serbia.
Ćirković I, Marković-Denić L, Bajčetić M, Dragovac G, Đorđević Z, Mioljević V, Urošević D, Nikolić V, Despotović A, Krtinić G, Rakić V, Janićijević I, Šuljagić V. Ćirković I, et al. Among authors: urosevic d. Antibiotics (Basel). 2022 Aug 28;11(9):1161. doi: 10.3390/antibiotics11091161. Antibiotics (Basel). 2022. PMID: 36139941 Free PMC article.
Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults).
Höybye C, Beck-Peccoz P, Murray RD, Simsek S, Stalla G, Strasburger CJ, Urosevic D, Zouater H, Johannsson G. Höybye C, et al. Among authors: urosevic d. Pituitary. 2021 Aug;24(4):622-629. doi: 10.1007/s11102-021-01139-2. Epub 2021 Mar 20. Pituitary. 2021. PMID: 33742320 Free PMC article.
Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6).
Pratley RE, Urosevic D, Boldrin M, Balena R; T-emerge 6 Study Group. Pratley RE, et al. Among authors: urosevic d. Diabetes Obes Metab. 2013 Mar;15(3):234-40. doi: 10.1111/dom.12009. Epub 2012 Sep 30. Diabetes Obes Metab. 2013. PMID: 22958426 Clinical Trial.
11 results